115 related articles for article (PubMed ID: 27722970)
1. Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the Infant.
Nordeng H; Spigset O
Drug Saf; 2005 Jul; 28(7):565-581. PubMed ID: 27722970
[TBL] [Abstract][Full Text] [Related]
2. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.
Nordeng H; Spigset O
Drug Saf; 2005; 28(7):565-81. PubMed ID: 15963005
[TBL] [Abstract][Full Text] [Related]
3. [Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].
Agut-Quijano T; Martínez-Nadal S; Elizari-Saco MJ; Sala-Castellví P; Vila-Cerén C; Raspall-Torrent F
Rev Neurol; 2006 Jun 1-15; 42(11):660-2. PubMed ID: 16736401
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of prenatal antidepressant exposure.
Simon GE; Cunningham ML; Davis RL
Am J Psychiatry; 2002 Dec; 159(12):2055-61. PubMed ID: 12450956
[TBL] [Abstract][Full Text] [Related]
5. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
Watanabe O
Seishin Shinkeigaku Zasshi; 2014; 116(12):996-1004. PubMed ID: 25823351
[TBL] [Abstract][Full Text] [Related]
6. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study.
Hutchison SM; Brain U; Grunau RE; Kuzeljevic B; Irvine M; Mâsse LC; Oberlander TF
BJPsych Open; 2023 Feb; 9(2):e26. PubMed ID: 36721917
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine use during pregnancy: is it safe?
Thormahlen GM
Ann Pharmacother; 2006 Oct; 40(10):1834-7. PubMed ID: 16926304
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in pregnancy and infant outcomes.
Jefferies AL;
Paediatr Child Health; 2011 Nov; 16(9):562-3. PubMed ID: 23115498
[TBL] [Abstract][Full Text] [Related]
9. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
10. Poor Neonatal Adaptation After Antidepressant Exposure During the Third Trimester in a Geographically Defined Cohort.
Brumbaugh JE; Ball CT; Crook JE; Stoppel CJ; Carey WA; Bobo WV
Mayo Clin Proc Innov Qual Outcomes; 2023 Apr; 7(2):127-139. PubMed ID: 36938114
[TBL] [Abstract][Full Text] [Related]
11. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.
Jimenez-Solem E; Andersen JT; Petersen M; Broedbaek K; Jensen JK; Afzal S; Gislason GH; Torp-Pedersen C; Poulsen HE
BMJ Open; 2012; 2(3):. PubMed ID: 22710132
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?
Diav-Citrin O; Ornoy A
Obstet Gynecol Int; 2012; 2012():698947. PubMed ID: 22190957
[TBL] [Abstract][Full Text] [Related]
13. Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Major Malformations: The Importance of Serotonin for Embryonic Development and the Effect of Serotonin Inhibition on the Occurrence of Malformations.
Bérard A; Levin M; Sadler T; Healy D
Bioelectricity; 2019 Mar; 1(1):18-29. PubMed ID: 34471805
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy Complications and Neonatal Mortality in a Serotonin Transporter Null Mouse Model: Insight Into the Use of Selective Serotonin Reuptake Inhibitor During Pregnancy.
Domingues RR; Wiltbank MC; Hernandez LL
Front Med (Lausanne); 2022; 9():848581. PubMed ID: 35360732
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors (SSRIs) in women of reproductive age: a systematic review of local formularies.
Lovegrove E; Maidwell-Smith A; Stuart B; Santer M
BJGP Open; 2024 May; ():. PubMed ID: 38272494
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine overdose during pregnancy.
Acar S; Erol H; Arslan EK; Uysal N; Karadaş B; Temiz TK; Cem Kaplan Y
Forensic Sci Res; 2021; 6(3):237-239. PubMed ID: 34868717
[TBL] [Abstract][Full Text] [Related]
17. The Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy.
Kieler H
Clin Epidemiol; 2010 Oct; 2():205-7. PubMed ID: 21042552
[TBL] [Abstract][Full Text] [Related]
18. Variation in the management of SSRI-exposed babies across England.
Thomas E; Peacock PJ; Bates SE
BMJ Paediatr Open; 2017; 1(1):e000060. PubMed ID: 29637109
[TBL] [Abstract][Full Text] [Related]
19. The Role of Medication, Mental Illness, and Social Isolation on the Development of the Fetus in the Context of the COVID-19 Pandemic.
Abdulla ZZ; Ferozuddin AA; Oviedo A
Cureus; 2023 Nov; 15(11):e48791. PubMed ID: 38098928
[TBL] [Abstract][Full Text] [Related]
20. Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy.
Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2014 Sep; 23(3):231-3. PubMed ID: 24786563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
